The faculty, fellows, residents, and staff from UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center will be prominently featured at the 2024 ASCO Annual Meeting, taking place May 31 – June 4, 2024 in Chicago, IL and online. Along with our colleagues, we will participate in one of the most significant gatherings of oncology professionals worldwide, making connections and forging collaborations that can change the landscape of cancer care.
Panel Moderators
Quality Care/Health Services Research
Charles Jiang, MD, MPH
Oral Abstract Session
May 31, 2024
2:45 PM – 5:45 PM CDT
Saboteurs: Identifying and Combating Your Saboteurs
Tian Zhang, MD, MHS
Panelist
June 1, 2024
3:15pm – 4pm CDT
Genitourinary Cancer—Kidney and Bladder
Suzanne Cole, MD
Oral Abstract Session
June 3, 2024
8:00 AM – 11:00 AM CDT
Presenters-Oral Poster Sessions
Oral Abstract Session
Quality Care/Health Services Research
Charles Jiang, MD, MPH
S100a | Live Stream
May 31, 2024
2:45 PM – 5:45 PM CDT
Targeting Direct and Indirect Costs of Cancer: Strategies for Screening, Intervention, and Policy
Rapid Oral Abstract Session
Prevention, Risk Reduction, and Genetics
Brian Reys, MS, CGC
S402 | On Demand
June 1, 2024
8:00 AM – 9:30 AM CDT
Abstract #: 10513
Tracking uncertainty in germline genetic testing for hereditary cancer syndromes: Sources, attributes, and resolution of variants of uncertain significance in over 1 million individuals.
Rapid Oral Abstract Session
Lung Cancer—Non-Small Cell Metastatic
Sawsan Rashdan, MD
S406 | On Demand
June 1, 2024
4:30 PM – 6:00 PM CDT
Abstract #: 8518
Safety and efficacy of osimertinib plus consolidative stereotactic ablative radiation (SABR) in advanced EGFR mutant non-small cell lung cancer (NSCLC): Results from a multi-center phase II trial
https://meetings.asco.org/abstracts-presentations/232890
CME program-Peer View
Maximizing the Role of ADCs in Urothelial Carcinoma
Practical Tips for Patient Selection, Safety Management, and Collaborative Care
1.5 CME/MOC/NCPD/AAPA/IPCE | ADCs IN BLADDER CANCER
Tian Zhang, MD, MHS
Live In-Person and Virtual Symposium
Saturday, June 1, 2024
6:30 – 7:00 PM CDT: Registration & Dinner
7:00 – 8:30 PM CDT: In-Person & Virtual Symposium
Registration Link: https://lrn.peerview.com/150209297_1/150209297_1_p1/stage1reg?AudienceID=PVI&Promocode=700&CountryID=US&ProjectNumber=150209297_1
CME program-Peer View
A Roadmap for Modern RCC Care
Navigating Personalized Treatment Selection and Sequencing
1.5 CME/MOC/NCPD/AAPA/IPCE | RENAL CELL CARCINOMA
Tian Zhang, MD, MHS
Live In-Person and Virtual Symposium on Sunday, June 2, 2024
6:30 – 7:00 PM CDT: Registration & Dinner
7:00 – 8:30 PM CDT: In-Person & Virtual Symposium
Registration Link: https://lrn.peerview.com/150209479_1/150209479_1_p1/stage1reg?CountryID=US&AudienceID=PVI&Promocode=700&ProjectNumber=150209479_1
Poster Sessions
OPERA-01: A randomized, open-label, phase 3 study of palazestrant (OP-1250) vs standard-of-care for ER+, HER2- advanced or metastatic breast cancer patients after endocrine therapy and CDK4/6 inhibitors.
Barbara Pistilli, Meritxell Bellet, Lucia Del Mastro, Heather McArthur, Jane Meisel, Peter Schmid, Joohyuk Sohn, Elisabeth De Kermadec, Rachel Wei, Arlene Chan
Poster Session
Hall A | On Demand
June 1, 2024
9:00 AM – 12:00 PM CDT
TPS1135
https://meetings.asco.org/2024%20ASCO%20Annual%20Meeting/15812?presentation=238278%23238278
Patterns of screening and access to care in women diagnosed with breast cancer in a safety-net system
Shifa Kanjwal, Malcolm Su, Madeleine Hopson, Sarah Kashanian, Chul Ahn, Samira Syed, Glenda Delgado Ramos, Nisha Unni, Navid Sadeghi
Poster Session
Hall A | On Demand
June 1, 2024
9:00 AM – 12:00 PM CDT
1531
https://meetings.asco.org/abstracts-presentations/233711
Safety, pharmacokinetics (PK), pharmacodynamics (PD) and efficacy of KT-253, a targeted protein degrader of MDM2, in patients with relapsed/refractory (R/R) solid tumors, lymphoma, high grade myeloid malignancies and acute lymphoblastic leukemia (ALL)
M. Rizwan Khawaja, Abdul Rafeh Naqash, Reva Schneider, Aditi Shastri, Maximilian Stahl, Justin Moser, Nagla Abdel Karim, Yazan Madanat, Brian Jonas, Eytan Stein, Shirish Gadgeel, James McCloskey, Ashwin Gollerkeri, Rachelle Perea, Yogesh Chutake, Sagar Agarwal, Patrick Henrick, Kelvin Shi, Naval Daver
Poster Session
Hall A | On Demand
June 1, 2024
9:00 AM – 12:00 PM CDT
3084
https://meetings.asco.org/abstracts-presentations/234158
An open-label, phase 1, multicenter study to evaluate the safety and preliminary anti-tumor activity of NT?112 in human leukocyte antigen-C*08:02–positive adult patients with unresectable, advanced, and/or metastatic solid tumors that are positive for the KRAS G12D mutation.
Salman Punekar, Meredith Pelster, Carlos Becerra, J. Hecht, Andrew Paulson, Patrick Grierson, Maria Pia Morelli, Rom Leidner, Mandana Kamgar, Joaquina Baranda, Syed Kazmi, Ardaman Shergill, Anne Robinson, Anuradha Patel, Ying Yan, Jeroen van Heijst, Nathan Demars, Arianne Perez, Sarah Cohen, Marwan Fakih
Poster Session
Hall A | On Demand
June 1, 2024
9:00 AM – 12:00 PM CDT
TPS2677
https://meetings.asco.org/abstracts-presentations/238320
Phase I dose-escalation and cohort expansion study of the anti-BTLA antibody, tifcemalimab, in combination with toripalimab (anti-PD-1) in heavily pretreated patients (pts) with advanced malignancies
Vincent Ma, Mohammed Milhem, Manuel Hidalgo, Anthony Shields, Jennifer Segar, Maya Khalil, Andrew Davis, Claire Verschraegen, Deborah Wong, Russell Schilder, Xin Gao, John Powderly, Yixing Jiang, Rahul Aggarwal, Farrukh Awan, Meredith McKean, Warren Chow, Sheng Yao, Patricia Keegan, Aung Naing
Poster Session
Hall A | On Demand
June 1, 2024
9:00 AM – 12:00 PM CDT
2596
https://meetings.asco.org/abstracts-presentations/233964
A phase 1b study of NC410 in combination with pembrolizumab in immune checkpoint inhibitor (ICI) naïve, and refractory microsatellite stable (MSS)/microsatellite instability-low (MSI-L) colorectal cancer (CRC) and ovarian cancer
Eric Christenson, Daruka Mahadevan, Syed Kazmi, Sudhir Manda, Davendra Sohal, Thomas Hutson, Siqing Fu, Ashley Martz, Stephanie Kordahi, Emilia Alina Barbu, Dallas Flies, Solomon Langermann, Michael Chisamore, Martin Gutierrez, Marc Matrana, Alex Spira, Raymond Wadlow, Udayan Guha, Han Myint, Dung Le
Poster Session
Hall A | On Demand
June 1, 2024
9:00 AM – 12:00 PM CDT
2538
https://meetings.asco.org/abstracts-presentations/233980
Safety and activity of Diakine DK210 (EGFR), a next generation tumor-targeted IL2 x IL10 dual immunocytokine, in patients with advanced cancer: Initial results of the phase 1 first-in-human trial.
Alexander Spira, Siqing Fu, Abdul Rafeh Naqash, Adanma Ayanambakkam, Syed Kazmi, Abhishek Tripathi, Aurelien Marabelle, Allison Long, Debra Kientop, Stanley Frankel, John Mumm, Douglas Orr
Poster Session
Hall A | On Demand
June 1, 2024
9:00 AM – 12:00 PM CDT
2584
Phase 1/2 study of NGM707, an ILT2/ILT4 dual antagonist antibody, in advanced solid tumors: Interim results from dose-escalation
Judy Wang, David Sommerhalder, Manish Sharma, William Edenfield, Kartik Sehgal, Do-Youn Oh, Yixing Jiang, Joel Michalski, Jeeyun Lee, Hans Hammers, Li-Yuan Bai, Chih-Hung Hsu, Brenda Dampier, Kefei Zhou, Lisa Blum, Joanne Lancaster, Dhiraj Abhyankar, Hsiao Lieu, Vladimir Hanes, Aung Naing
Poster Session
Hall A | On Demand
June 1, 2024
9:00 AM – 12:00 PM CDT
2582
Two phase 2A clinical trials to evaluate the safety and efficacy of IMSA101 in combination with radiotherapy and checkpoint inhibitors in oligometastatic and oligoprogressive solid tumor malignancies.
Percy Lee, Jyoti Malhotra, Jason Salsamendi, Mona Arbab, Tithi Biswas, Andrew Baschnagel, Matthew Deek, Edward Garmey, Daniel Hamstra, Mai Anh Huynh, Aryavarta Kumar, Devalingam Mahalingam, Benjamin Maughan, Teresa Mooneyham, Nitin Ohri, Krishna Reddy, Gregory Vlacich, Patrick Widhelm, Jason Ye, Robert Timmerman
Poster Session
Hall A | On Demand
June 1, 2024
9:00 AM – 12:00 PM CDT
TPS2685
Post-progression therapies and outcomes for patients with advanced, BRCA-related pancreatic cancer after receipt of PARP inhibitors: A national retrospective cohort study
Baqir Jafry, Syed Kazmi, Salwan Al Mutar, Kim Reiss, Timothy Brown
Poster Session
Hall A | On Demand
June 1, 2024
1:30 PM – 4:30 PM CDT
4156
https://meetings.asco.org/abstracts-presentations/234344
A phase 1 dose-escalation and expansion study of an intratumorally administered dual STING agonist (ONM-501) alone and in combination with cemiplimab in patients with advanced solid tumors and lymphomas.
Julia Foldi, Sarina Piha-Paul, Liza Villaruz, Heather McArthur, Madeline Olson, Euodia Jonathan, Brian Ostrander, Kartik Krishnan, Jason Luke
Poster Session
Hall A | On Demand
June 2, 2024
9:00 AM – 12:00 PM CDT
TPS2693
https://meetings.asco.org/2024%20ASCO%20Annual%20Meeting/15821?presentation=238330%23238330
Phase 2 trial for sequential treatment of high dose cabozantinib (CABO) or CABO plus nivolumab (NIVO) on/after progression on CABO monotherapy in advanced renal cell carcinoma (RCC): Seq-Cabo
Qian Qin, James Brugarolas, Hans Hammers, Waddah Arafat, Kevin Courtney, Jue Wang, Changchuan Jiang, Song Zhang, Charles Cowey, Thomas Hutson, Tian Zhang
Hall A | On Demand
June 2, 2024
9:00 AM – 12:00 PM CDT
TPS4609
https://meetings.asco.org/abstracts-presentations/238856
Treatment outcomes for patients with Ga68-PSMA-PET prostate cancer (PC) with or without conventional imaging correlates.
Wadih Issa, Maureen Aliru, Damla Gunenc, Song Zhang, Qinhan Zhou, Qian Qin, Jue Wang, Waddah Arafat, Kevin Courtney, Daniel Yang, Neil Desai, Aurelie Garant, Raquibul Hannan, Jeffrey Cadeddu, Kris Gaston, Solomon Woldu, Vitaly Margulis, Yair Lotan, Andrew Wang, Tian Zhang
6/2/2024
Poster Session
Hall A | On Demand
June 2, 2024
9:00 AM – 12:00 PM CDT
5078
Access barriers and cost of varenicline for smoking cessation: A national comparative analysis of Medicare standalone part D and Medicare Advantage plan
Changchuan Jiang, Qian Wang, Arthur Hong, Megan Mullins, Jiazhang Xing, Tianci Wang, Xin Hu, Ryan Nipp, Robin Yabroff, Joshua Liao, Xuesong Han, Ya-Chen Shih
Poster Session
Hall A | On Demand
June 3, 2024
9:00 AM – 12:00 PM CDT
11080
https://meetings.asco.org/abstracts-presentations/233244
Intensification of ADT with enzalutamide in high-risk patients with biochemical relapse following radical prostatectomy undergoing salvage radiation: Initial results from RTOG 3506 (STEEL).
Edwin Posadas, Hiram Gay, Joseph Rodgers, Todd Morgan, Ying Xiao, James Yu, Jeff Michalski, Myriam Bouchard, Neil Desai, Ryan Funk, Thomas Boike, Donald Jurgens, Anthony Wong, Xinglei Shen, Lloyd Miyawaki, Christopher Bland, John Hairston, Howard Sandler, Stephanie Pugh, Felix Feng
Poster Session
Hall A | On Demand
June 2, 2024
9:00 AM – 12:00 PM CDT
5101
Evorpacept plus enfortumab vedotin in patients (Pts) with locally advanced or metastatic urothelial carcinoma (la/mUC): Phase 1a dose escalation results.
Samuel Funt, Petros Grivas, Xin Gao, Daniel Vaena, Tian Zhang, Matthew Milowsky, Mayank Rao, Harry Liu, Kimberly Tipton, Grace An, Feng Jin, Alison Forgie, Sophia Randolph, Athanasios Tsiatis, Rohit Jain
Poster Session
Hall A | On Demand
June 2, 2024
9:00 AM – 12:00 PM CDT
4575
LIBERTAS: A degendered and transgender-inclusive phase 3 study of apalutamide (APA) plus intermittent vs continuous androgen deprivation therapy (ADT) in participants (pts) with metastatic hormone-sensitive prostate cancer (mHSPC).
Arun Azad, Clark Musto, Shir Netanel, Tian Zhang, Dana Rathkopf, Marco Badillo, Qiang Dong, Alicia Morgans, Karie Runcie, Alex Dos Santos, Amitabha Bhaumik, Suneel Mundle, Sharon McCarthy, Angela Lopez- Gitlitz, Ashita Batavia, Daniel Sanchez, Mark Wildgust, Neeraj Agarwal
Poster Session
Hall A | On Demand
June 2, 2024
9:00 AM – 12:00 PM CDT
TPS5119
Efficacy of imetelstat on red blood cell (RBC)-transfusion independence (TI) in the absence of platelet transfusions or myeloid growth factors in IMerge
Amer Zeidan, Valeria Santini, Uwe Platzbecker, Mikkael Sekeres, Michael Savona, Pierre Fenaux, Yazan Madanat, Azra Raza, Qi Xia, Libo Sun, Jennifer Riggs, Sheetal Shah, Shyamala Navada, Tymara Berry, Rami Komrokji
6/3/2024
Poster Session
Hall A | On Demand
June 3, 2024
9:00 AM – 12:00 PM CDT
6566
https://meetings.asco.org/abstracts-presentations/232598
Mutation profiles and outcomes of patients with acute myeloid leukemia with autoimmune disease
Sarah Philip, Eno-obong Udoh, Xiaoying Chen, Wei Wei, Yazeed Sawalha, Yazan Madanat, Ameera Rose, Teodora Kuzmanovic, Ronald Sobecks, Betty Hamilton, Sudipto Mukherjee, Aaron Gerds, Hetty Carraway, Jaroslaw Maciejewski, Mikkael Sekeres, Anjali Advani
Poster Session
Hall A | On Demand
June 3, 2024
9:00 AM – 12:00 PM CDT
6536
https://meetings.asco.org/abstracts-presentations/232611
Administrative burden of establishing health care coverage for the uninsured and its impact on timely access to care.
Laura Wang, Arthur Hong, Aman Narayan, Navid Sadeghi, Ethan Halm
Poster Session
Hall A | On Demand
June 3, 2024
9:00 AM – 12:00 PM CDT
11050
Phase 1/2 trial of the XPO1 inhibitor selinexor in combination with docetaxel in previously treated, advanced KRAS mutant non-small cell lung cancer (NSCLC)
Mitchell von Itzstein, Timothy Burns, Jonathan Dowell, Leora Horn, David Camidge, Sally York, Keith Eaton, Christopher Walker, Song Zhang, David Gerber
Poster Session
Hall A | On Demand
June 3, 2024
1:30 PM – 4:30 PM CDT
8597
https://meetings.asco.org/abstracts-presentations/232193